Close Menu

NEW YORK (GenomeWeb) – Researchers from Boston and Los Angeles have devised a new sequencing approach to gauge N6-methyladenosine modifications of RNA molecules.

N6-methyladenosine (m6A) is a reversible chemical modification of mRNAs and long noncoding RNAs. While such modifications have been linked to RNA metabolism, not much is known about how common modified transcripts are and what their regulatory effect is, the researchers noted.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.